BREAST CANCER BASE

Extended cycle of chemotherapy on breast cancer patients useful A 10-year study showed that the node-positive breast cancer before menopause women to accept if epirubicin-based six cycles of chemotherapy...

What is a progesterone-like drug, the application Progesterone drugs in the treatment of breast cancer efficiency of 16% to 20%. Clinical found that the local recurrence and metastasis of so...

The obesity to breast cancer chemotherapy patients, clinicians account of the distribution and drug toxicity, it is usually to reduce the dosage of chemotherapy drugs, but in fact, support this approach to the data is limited. Italian researchers recently found that obese patients with breast cancer to reduce the first dose chemotherapy regimen is not appropriate. The researchers collected several items of body mass index, chemotherapy dose, estrogen receptor expression and postmenopausal breast cancer patients prognosis of the randomized clinical research data. The results showed that a very high percentage of obese patients in the first chemotherapy regimen used in the dose of conventional doses of 85% or less. But their prognosis with those receiving conventional-dose chemotherapy compared to patients there was no significant difference. The latter disease-free survival and overall survival was even slightly higher than the 15.83 persons. Obese patients with conventional-dose chemotherapy has not been as expected those that have more side effects. The researchers do not recommend reducing obesity in patients with breast cancer chemotherapy dose.

The transfer of the central nervous system chemotherapy The transfer of the central nervous system chemotherapy 1. The absence of cerebral edema, using x-ray tomography positioning, given radiat...

Treatment of breast cancer often choose which chemotherapy? Almost all anti-cancer drugs in cell division play a role. As normal cells as cell division frequent, less susceptible to anti-cancer drugs...

Bone marrow transplantation will not help in the treatment of breast cancer The new study found that advanced breast cancer patients after bone marrow transplantation, with only chemotherapy patients compared to no d...

Application of breast cancer after Femara for endocrine therapy? No chemotherapy directly with Femara work? The world at present, after receptor-positive breast cancer patients using complementary therapy...

Breast cancer chemotherapy on the latest research progress The 26th San Antonio Breast Cancer Conference, in the radiotherapy of breast cancer has many important studies, the specific details relate...

The U.S. Food and Drug Administration approved paclitaxel for the treatment of early breast cancer     由于该管理局咨询委员会全体成员的一致推荐，今年九月份，美国食品与药物管理局批准，在阿霉素�...

Breast Cancer Metastasis

Eight-induced breast cancer risk